Medherant
Coventry
About Medherant
Medherant was founded by Professor David Haddleton and the University of Warwick to develop and commercialise novel transdermal drug delivery platforms. Current patch technologies have limited drug loading capabilities, making them unviable for use with many pharmaceutical products that could benefit from transdermal delivery. Creams and gels on the other hand suffer from a lack of dose control that is critical for many drugs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $11.2M
- Last round: Series Unknown (Apr 2023)
- Website: medherant.co.uk
- Phone: +442476323060
Industries & Categories
Commercial, Delivery, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/medherant-21146 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.